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I. Background 
 
 The major components of maternal behavior in the rat include retrieval behavior, 
nest building, pup grooming, and nursing behavior (Numan & Insel, 2003). Retrieval 
behavior occurs when a postpartum female takes an individual pup in her mouth and 
transports it to her current nest site or to a new nest site. Nest building is essential to keep 
poikilothermic pups warm in the absence of the mother while nursing behavior, in which 
the mother crouches over the pups and exposes her mammary region, enables the pups to 
feed from the mother’s teat. Licking and grooming of the pups aid urination and 
defecation.  
 These maternal behaviors, which are essential for the survival of the litter, are 
synchronized with the birth of the young. At parturition, a primiparous female will 
exhibit immediate maternal behavior toward her offspring (Numan & Insel 2003). In fact, 
the female rat will even care for pups from another mother (foster pups). This 
unconditional maternal responsiveness toward pups is under the control of certain 
hormonal mechanisms that are active during pregnancy and pregnancy termination. 
Virgin females, who have never been exposed to these hormonal fluctuations, will ignore 
or in some cases attack the pups that are presented to them.  
Although the virgin female will not automatically respond maternally to pups 
during the first exposure, she eventually begins to display maternal behavior if she is 
exposed repeatedly to pup stimuli over a period of several days (Fleming & Rosenblatt, 
1974; Numan & Insel, 2003; Rosenblatt, 1967).  Fleming and Rosenblatt (1974) 
demonstrated that the virgin female transitions from active avoidance to tolerance of pups 
and finally, initiates maternal care. The cages in which the females were tested were 
divided into four quadrants by plastic crossbars, which allowed the female to cross easily 
while the pups remained within one quadrant. Prior to testing, each female exhibited a 
preferred nesting quadrant. When pups were placed into this quadrant on the first test 
day, the virgin female tended to actively avoid the pups and relocate her nest to a new 
quadrant. With each subsequent day, pups were placed in the female’s new nest and she 
continued to actively avoid. After approximately 3-4 days, the female begins to tolerate 
their proximity. Finally, 6-8 days from initial exposure to pups, the female displays the 
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full complement of maternal behaviors: she retrieves all of the pups to a single quadrant, 
creates a nest area around them, and licks and grooms them. The virgin female even 
adopts nursing postures over the pups despite the fact that she cannot lactate. This 
dramatic behavioral transformation is termed sensitized maternal behavior and the 
process is called sensitization. A female’s sensitization latency consists of the number of 
days of pup exposure required before she initiates maternal behavior. During the 
sensitization process, virgin females are presented daily with freshly nourished pups 
taken from a postpartum female. The daily exchange of pups is necessary because the 
virgin female does not produce milk to feed the pups. While the hormonal events of 
pregnancy and parturition are not essential for the display of maternal behavior, they 
seem to reduce the amount of pup exposure necessary before appropriate maternal 
responses are initiated.  
What hormones are involved in the modification of neural processes involved in 
maternal behavior? During the 22-23 day pregnancy, estradiol and progesterone are 
released from the ovary and lactogens are secreted from the placenta and anterior 
pituitary. The female is exposed to chronic lactogenic stimulation and progesterone 
secretion, which stimulates mammary development and promotes gestation. However, as 
the female rat nears the end of her pregnancy term, progesterone levels must decrease in 
preparation for birth while estradiol and lactogenic levels remain high. In the days 
directly preceding parturition, the female rat experiences a maximum level of estradiol 
and minimum level of progesterone in her bloodstream. This high-low combination 
enables the parturient female to exhibit immediate behavior toward her offspring (Numan 
& Insel, 2003). 
 One strategy to induce the immediate display of maternal behavior involves the 
pregnancy termination model, which manipulates the nature of hormonal treatment on 
neural circuits. (Rosenblatt, Olufowobi, & Siegel, 1998; Rosenblatt & Siegel, 1975; 
Siegel & Rosenblatt, 1975). The artificial termination of pregnancy by hysterectomy 
(removal of the fetuses, placenta, and uterus) on day 15 induces hormonal events similar 
to those which occur at birth, thus stimulating a rapid onset of maternal behavior. By day 
15, two-thirds of the way through gestation, estradiol levels are beginning to rise while 
prolactin levels remain quite high. Removal of the placentas, which are the main 
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stimulation of progesterone secretion by the corpora lutea at this time, produces a 
precipitous decline in progesterone. Consequently, the day-15 hysterectomized female 
(15H) experiences high estradiol and low progesterone levels; when presented with pups 
48 hr after hysterectomy surgery, the 15H female shows an immediate onset of maternal 
behavior. Concurrent ovariectomy (15HO), which blocks the rise of estradiol by 
removing the ovaries, delays the onset of maternal behavior to approximately 2-3 days 
and demonstrates the importance of not only progesterone withdrawal, but rising estradiol 
in the stimulation of maternal behavior. Importantly, estradiol administered at the time of 
hysterectomy-overiectomy surgery (15HO + E) reinstates an immediate onset of maternal 
responsiveness. The 15HO female has a latency that is somewhere in between the 
latencies of the virgin female (6-8 days) and the 15HO + E female (0 days) (See Table 1). 
Thus, even without a rise in estradiol following pregnancy termination, there is some 
stimulation of maternal responsiveness that occurs. The 15HO female can therefore be 
considered partially primed.  
 The hormonal events during the end of pregnancy prime neural circuits, 
potentiating the ability of pup stimuli to initiate maternal behavior. The medial preoptic 
area (MPOA) of the rostral hypothalamus is one neural site where hormones act to 
promote the parturient female’s responsiveness toward pups. It is well established that an 
intact MPOA is necessary for normal maternal behavior in rats. The MPOA receives 
olfactory and tactile sensory input from pups (Numan & Insel, 2003) and when its lateral 
connections are severed using electrical lesions or knife cuts, maternal behavior is 
disrupted. Of note, excitotoxic amino acid lesions of the MPOA, which only damage cell 
bodies and spare fibers of passage, depress maternal behavior (Numan, Corodimas, 
Numan, Factor & Piers, 1988). This data suggests that damage to both the MPOA 
neurons and its lateral efferents play an essential role in maternal behavior. All studies 
agree that females experience the greatest disruption in retrieval behavior and 
nestbuilding when the MPOA is damaged (Numan & Insel, 2003). Interestingly, it seems 
that the MPOA specifically regulates maternal behavior. As a result of MPOA damage, 
sexual behavior, locomotor activity, body weight regulation, and hoarding behavior all 
remain intact while retrieval and nestbuilding are abolished. The female’s display of 
hoarding behavior is particularly relevant because it demonstrates that MPOA damage 
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does not cause an oral motor deficit; although the female does not retrieve pups, she 
retains the ability to transport candy of the same size and shape as pups in her mouth 
(Numan & Corodimas, 1985). 
 While MPOA damage depresses maternal behavior, hormone action on the 
MPOA actually stimulates maternal behavior. The MPOA contains estrogen receptors 
(Shugurue, Lane & Merchenthaler, 1997), progesterone receptors (Numan, Roach, del 
Cerro, Guillamon, Segovia, Sheehan & Numan, 1999) and prolactin receptors (Bakowska 
& Morrell, 1997), making it a likely site for hormones to engage neural circuits in the 
regulation of maternal behavior. Studies have shown that implants of estradiol (Numan, 
Rosenblatt & Komisaruk, 1977) or prolactin/placental lactogens (Bridges, Numan, 
Ronsheim, Mann & Lupin, 1990; Bridges, Robertson, Shiu, Sturgis, Henriquez & Mann, 
1997) into the MPOA can promote the onset of complete maternal behavior in rats. 
Fahrbach, Morrell, and Pfaff (1986) have shown that estradiol-binding receptors in the 
MPOA project to the ventral tegmental area (VTA), which is the origin of the mesolimbic 
dopamine (DA) pathway. Central to our current study is the idea that one of the ways the 
MPOA and its output circuits affect maternal behavior is through their interaction with 
the mesolimbic DA system. In conjunction with the findings made by Fahrbach et al. 
(1986), our current hypothesis suggests that maternal behaviors that are regulated by 
estrogen action in the MPOA may be controlled by the direct hormone-sensitive pathway 
to the VTA. Hormone action on the MPOA may allow pup stimuli to activate MPOA 
efferents to the VTA and in turn, promote the female’s responsiveness to pups. 
In support of this hypothesis, Numan & Numan (1996, 1997) have shown that 
neurons in the MPOA that express Fos proteins (c-Fos and Fos B) during maternal 
behavior project directly to the VTA. The Fos protein is part of a group of immediate 
early genes (IEG) that is transcribed within minutes of neuronal stimulation (for example, 
by a hormone, neurotransmitter, or neuromodulater). IEGs play a regulatory role in the 
neuron, influencing how extracellular events are translated into genomic action. The 
expression of Fos proteins is an indication that neurons have been stimulated by 
hormonal input (Sheng & Greenberg, 1990), suggesting that the MPOA and its efferent 
output to the VTA are key participants in the neural circuitry underlying maternal 
behavior in rats. Sheehan and Numan (2002) have shown that the hormonal events 
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associated with pregnancy termination lead to an increased expression of Fos protein in 
MPOA neurons. Additionally, the MPOA also shows increased Fos expression when the 
postpartum female interacts with her pups (Lonstein & DeVries, 2000) and while she is 
searching an environment that previously contained pups (Mattson & Morrell, 2005).  
It is important to define what types of neurons in the MPOA express Fos during 
mother-pup interactions and to explore where these neurons terminate. Lonstein, Greco, 
DeVries, Stern, and Blaustein (2000) used double labeling immunohistochemical 
procedures to show that MPOA neurons that express Fos during maternal behavior also 
express estrogen receptor α. Further, neurons in the MPOA that bind estradiol project to 
the VTA (Farbach, Morrell, & Pfaff, 1986). Finally, as previously mentioned, Numan & 
Numan (1997) have shown that MPOA neurons activated during maternal behavior, as 
indicated by increased Fos expression, also project to the VTA. Although a triple-labeling 
study has yet to be conducted, evidence strongly suggest that neurons of the MPOA 
which bind estradiol and express Fos during maternal behavior terminate in the VTA.  
With respect to this hypothesis, Numan and Smith (1984) conducted an 
asymmetrical lesion study to explore whether the combined disruption of the MPOA and 
VTA would depress or abolish maternal behavior. Unilateral lesions of the MPOA alone 
do not disrupt maternal behavior. Similarly, unilateral lesions of the MPOA paired with 
unilateral damage to the VTA on the ipsilateral side of the brain has no effect on maternal 
responsiveness. It is only when a unilateral MPOA lesion is paired with a unilateral 
lesion of the VTA on the contralateral side of the brain that ongoing maternal behavior is 
disrupted in lactating rats.  These data support the hypothesis that hormone action on the 
MPOA stimulates maternal behavior through the activation of efferent outputs to the 
VTA. 
The mesolimbic DA system originates from the VTA and finds one of its major 
termini in the nucleus accumbens (NA). Mesolimbic DA projections from the VTA to the 
NA have been hypothesized to modulate the impact of sensory stimuli on behavior. 
Specifically, this pathway facilitates the ability of sensory stimulation to elicit appropriate 
motor responses (Berridge & Robinson, 1998; Horvitz, 2002).  To build on our current 
hypothesis that hormone action on the MPOA allows pup stimuli to activate efferents to 
the VTA, we hypothesize that activation of the VTA leads to dopamine release into the 
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nucleus accumbens (NA) and ultimately elicits the motor responses associated with the 
initiation of maternal behavior. A substantial amount of evidence supports the idea that 
the mesolimbic DA system plays an essential role in the facilitation of maternal behavior. 
The VTA contains dopamine cell bodies that project to the NA and during mother-pup 
interactions, there is increased DA release into the NA (Champagne, Chretien, Stevenson, 
Zhang, Gratton, & Meaney, 2004). Electrical lesions of the VTA (Gaffori & Le Moal, 
1979) and DA depletions caused by 6-hydroxydopamine lesions (6-OHDA), which 
specifically destroy DA neurons of the either VTA or NA (Hansen, Harthon, Wallin, 
Loftberg & Svensson, 1991a, 1991b) disrupt maternal behavior. Various studies have 
also shown that microinjections of DA receptor antagonists into the NA disrupt maternal 
behavior in postpartum rats (Keer & Stern, 1999; Numan, Numan, Pliakou, Stolzenberg, 
Mullins, Murphy & Smith, 2005a). It is important to consider that the downregulation of 
DA in the VTA or NA primarily affects the proactive or voluntary components of 
maternal behavior such as retrieval behavior and nestbuiliding, while nursing behavior is 
much less affected (Hansen et al., 1991a; Keer & Stern, 1999). The behavioral deficits 
incurred from damage to the VTA or dopamine neurons in the NA are strikingly similar 
to deficits from damage to the MPOA. Evidence demonstrating these parallel effects 
further strengthens the hypothesis that MPOA and mesolimbic DA circuits interact with 
each other to influence maternal behavior.   
  Numan et al. (2005a) have shown through their investigation of DA receptor 
blockade in the NA that the disruption of maternal behavior was selectively mediated by 
D1 DA receptors. The NA contains two main subtypes of DA receptors: the D1 and D2 
type receptor. Given that 6-OHDA lesions (Hansen et al., 1991 a, b) and microinjections 
of a mixed D1-D2 receptor antagonist into the NA (Keer & Stern, 1999) cause disruptions 
in voluntary maternal behavior, it is important to differentiate which receptor subtype is 
involved. The Numan group investigated impairments of the proactive voluntary 
components of maternal behavior using both a standard D1 receptor antagonist (SCH 
23390) and a standard D2 receptor antagonist (eticlopride). Postpartum females were 
injected with either various doses (0, 1, and 3µg) of SCH 23390 or eticlopride into the 
shell region of the NA and the effects on maternal behavior were observed. While 
nursing behaviors remained relatively intact, microinjection of the D1 receptor antagonist 
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caused significant disruption of retrieval behavior in a dose-dependent fashion, while the 
D2 receptor antagonist did not cause any such deficits. It is important to note that both 
experimental and control females promptly approached the pups that were placed outside 
of the female’s nest area. In addition, some females treated with the D1 receptor 
antagonist actually retrieved some of their pups (usually 1-2 pups out of 6 total), 
demonstrating that they had the ability to perform the response. The behavioral deficit 
centered on the female’s inability to retrieve all of her pups to her nest area. One 
interpretation from these data might be that D1 receptor antagonism in the NA decreases 
the ability of pup stimuli to elicit proactive voluntary maternal responses. 
 The above studies demonstrate that interference with the mesolimbic DA system 
at the level of the NA disrupts maternal behavior. However, it is important to examine 
whether increased DA activity in the NA can stimulate the onset of maternal behavior. A 
recent study conducted by Stolzenberg, McKenna, Keough, Hancock, Numan, and 
Numan (2007) has shown that the upregulation of DA in the NA facilitated the onset of 
maternal behavior in females that were suboptimally hormone primed. Using the 15HO 
preparation, Stolzenberg et al. showed that partially primed females who would normally 
show 2-3 day sensitization latencies could be induced to show almost immediate onset of 
maternal behavior by microinjection of DA D1 receptor agonist (SKF 38393) to the NA. 
15HO females who were injected with a 0.5µg dose of SKF 38393 showed a sensitization 
latency of approximately 0.5 days, which was significantly shorter than the 2-day latency 
of those 15HO females who received 0µg of the drug (control group). Importantly, 90% 
of females receiving the 0.5µg dose of SKF 38393 were maternal by Day 1 of testing 
compared with only 33% of females in the control group. On the basis of evidence 
indicating that estradiol injection into the MPOA of 15HO females induces maternal 
behavior, the finding that DA D1 receptor agonist injection into the NA stimulated almost 
immediate onset of maternal behavior in 15HO females suggests that activation of DA D1 
receptors in the NA takes the place of estradiol action on the MPOA. 
 With the understanding that DA action on D1 receptors in the NA facilitates 
maternal behavior, how exactly does DA carry out this facilitatory effect? The 
mesolimbic DA system regulates behavioral responsiveness to sensory stimuli through its 
projection to the NA (Numan, 2006). The NA receives the majority of its other inputs 
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from limbic structures and this input is primarily glutamatergic (Pennartz,  Groenewegen, 
& Lopes Da Silva, 1994). Medium spiny neurons (MSN), the major output neurons of the 
NA, project to a basal ganglia motor nucleus called the ventral pallidum (VP) and are 
GABAergic (Pennartz et al., 1994). Gordon Mogenson (1987) argued that DAergic input 
inhibits excitatory transmission in the NA and that this effect releases the VP from 
inhibition by NA GABAergic efferents. The consequent increase in activity in the VP 
stimulates behavioral activity. The Mogenson study (1987) has shown that increased DA 
release into the NA (either by stimulation of the VTA or by exogenous administration) 
increased locomotor activity in an open field, and that this effect could be blocked by 
pharmacological depression of the VP. Given that the NA-to-VP projection is important 
to locomotion and that increasing the GABAergic input to the VP depressed motor 
activity, Mogenson concluded that DA increases motor activity by reducing NA 
GABAergic output to the VP, or by disinhibiting the VP.  
 Mogenson deemed stimulation of VP efferents essential for behavioral 
responsiveness. However, the mechanism mediating the Na-to-VP circuit is controversial 
and subject to multiple research findings. The classical view espoused by Nicola, 
Surmeier, and Malenka (2000) poses that DA action on D1 receptors in the NA increases 
the responsiveness of NA neurons to excitation, suggesting that stimulation and not 
inhibition of NA efferents is essential to maternal behavior. Although the Mogenson 
model is controversial, our laboratory has produced findings that advocate the 
neuromodulatory inhibition of NA efferents by DA. As previously noted, increased DA 
action on the NA facilitates maternal behavior (Stolzenberg et al., 2007) while 
interference with VP activity disrupts maternal behavior (Numan, Numan, Schwarz, 
Neuner, Flood, & Smith, 2005b). While VP output is critical for maternal behavior, NA 
output is not: NA lesions do not disrupt maternal responsiveness. Similar to results 
presented by Mogenson et al., these data demonstrate that DA activity in the NA 
depresses GABAergic NA-to-VP projections and releases the VP from inhibition. 
 Further research has shown that the MPOA interacts with the NA-to-VP circuit to 
influence maternal behavior. Using an asymmetrical lesion design, Numan et al. (2005b) 
lesioned the MPOA on one side of the brain and lesioned the VP on the contralateral side. 
Control animals received either ipsilateral lesions of the VP and MPOA or contralateral 
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sham lesions. Experimental animals showed a significant deficit in pup retrieval 
behavior, though they did not exhibit oral motor deficits. In light of the fact that unilateral 
lesions of the MPOA alone do not disrupt maternal behavior, this finding suggests that 
the MPOA and VP are functionally linked.  
 Given the major role the MPOA plays in the onset and maintenance of maternal 
behavior, it is interesting that the MPOA itself receives DA input and constitutes an 
important part of the dopaminergic systems that regulate motivational behavior. Simerly, 
Gorski, and Swanson (1986) used antiserum to DA β-hydroxylase to demonstrate that the 
MPOA receives DAergic input from DA cell bodies in the periventricular hypothalamic 
region. Further, the MPOA of pregnant female rats contains DA D1 and D2 receptors and 
the densities of these receptors fluctuate through pregnancy (Bakowska & Morrell, 1995). 
To explore the possibility that DA action at the level of the MPOA facilitates maternal 
behavior, Stolzenberg et al. (2007) stimulated D1 DA receptors in the MPOA. Using the 
15HO model and a 0.5µg dose of a D1 receptor DA agonist  (SKF 38393), which 
effectively stimulated maternal behavior when injected into the NA, Stolzenberg et al. 
showed that microinjection of SKF 38393 into the MPOA was equally effective in 
stimulating the onset of maternal behavior as it had been in the NA. While the data shows 
that activation of DA receptors in the MPOA facilitates the onset of maternal behavior, 
the exact role of DA in the MPOA is not completely understood and is subject to mixed 
findings (See Miller & Lonstein, 2005; Numan et al., 2005a). Based on the literature 
reviewed, it is likely that D1 DA receptor activation in both the MPOA and NA is 
important for the onset of maternal behavior. In the 15HO female that is not treated with 
estradiol, the level of DA and density of DA receptors is low. Increasing DA activity on 
D1 receptors in either the MPOA or NA substitutes for estradiol action on the MPOA by 
increasing the sensitivity of MPOA neurons to sensory inputs, thus facilitating a rapid 
onset of maternal responsiveness.  
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Table 1. Average Sensitization Latencies for Female Rats Exposed to Different 
Treatments. 
 
Treatment 
 
Average Sensitization Latency (days) 
Naïve virgin female 6-8 
15HO female 2-3 
15HO + E female 0 
 
Note. 15HO, females who underwent hysterectomy-ovaariectomy surgery on day 15 of a 
22-day pregnancy; 15HO + E, females who received estradiol benzoate (sc) at the time of 
surgery. 
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Figure 1.    A proposed neural model of MPOA interaction with the mesolimbic DA 
system in the regulation of maternal behavior. See text for details. MPOA, medial 
preoptic area; VTA, ventral tegmental area; DA, dopamine; D1, D1 dopamine receptor; 
GABA, gamma-aminobutyric acid; VP, ventral pallidum.  
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VTA 
D1 
  NA 
   VP 
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II. General Method 
Subjects 
 All subjects were nulliparous cycling females of the Charles River CD strain 
(Charles River Labs, Wilmington, MA), and ranged in age from 70-100 days of age at the 
time of mating. Each female was mated by placing her with a male of the same strain 
overnight during proestrus. The day of mating was considered Day 0 of pregnancy. 
 An additional group of females were used as donor mothers to provide freshly 
nourished pups for the experimental females. These females were also of the Charles 
River CD strain. They were mated and allowed to give birth naturally.  
 
 Housing and Maintenance 
 Prior to mating, experimental females were housed with one or two other 
nulliparous females in clear polycarbonate cages measuring 20 x 45 x 20 cm. On the 
morning following mating, Day 1, females were transferred to clear polycarbonate cages 
(20 x 45 x 20 cm) in which they were housed singly. At 24 hr prior to surgery (day 14), 
females were transferred to clear polycarbonate observation cages measuring 50 x 40 x 
20 cm. The floors of these cages contained pine wood shavings for bedding material and 
were divided into four equal quadrants by 5-cm high Plexiglas crossbars, which were 
meant to prevent pups from crawling from one quadrant of the cage to another. 
 Donor females and their litters were housed in a room separate from experimental 
females, in polycarbonate cages (20 x 45 x 20 cm) containing wood shavings.  
 All females were maintained under a 12-hour reversed day-night cycle (lights on 
from 1800 h to 0600 h) and under a relatively constant temperature of 21°C. Food pellets 
and water were freely available. Behavioral observations occurred during the dark phase, 
and test rooms were illuminated with a dim red light.   
 
Surgery 
 Cannula implantation was performed on Day 1 of pregnancy. This stereotaxic 
surgery was carried out under Nembutal anesthesia (50mg/kg ip) and atropine sulfate 
pretreatment (0.2mg/kg ip). Following surgery, subjects were injected with penicillin 
(50,000 units/kg sc) and were placed underneath a heating lamp during recovery. 
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Bilateral 22-gauge stainless steel guide cannulas (Plastics One, Roanoke, VA) were 
implanted into the NA. The DeGroot (1959) stereotaxic atlas was used and interaural zero 
served as the reference point. Coordinates for NA guide cannula implants were: A 9.5,  
L ± 1.0, V 7.0. Dental acrylic was used to cement the implanted cannulae to the skull. 
Once implanted, dental acrylic was used to cement the cannulae to the skull. The 
implanted cannulae were occluded with stainless steel stylets that extended 2 mm beyond 
the end of the guide. 
 Hysterectomy and overiectomy surgery was performed on Day 15 of pregnancy 
via dorsolateral and ventral incisions while the animal was under Nembutal anthesthesia. 
The surgery included the removal of two uteruses, including fetuses and placenta, and the 
attached ovaries. The uterine horns were severed at the tubo-uterine junction and at the 
anterior end of the cervix. The uterine horns and ovaries were removed through a mid-
ventral incision and incision was closed using sutures and metal wound staples.  
 
Measurements and Observations 
 Behavioral testing occurred 48 hr after hysterectomy and overiectomy surgery, 
deemed Day 0 of testing. Observations commenced when 3 test pups between 2-7 days in 
age  (obtained from donor mothers) were placed throughout the female’s cage (one in 
each quadrant other than the female’s nesting quadrant) between 1000 h and 1100 h on 
each day. Younger pups were presented earlier in the testing period, while older pups 
were presented later. During the first hour of pup exposure, subjects were continuously 
observed for the first 15 min, spot-checked at 30 min, and observed continuously again 
for the last 15 min. Observations included: location and behavior of the female; location 
of the pups; whether the female retrieved any/some/all pups and grouped them into a 
single nest area; and whether the female adopted a nursing posture over the young. Sniff 
latency was also recorded. Subjects that did not sniff the pups by the end of the first 15-
minute period were manually moved by the experimenter so that they could sniff the pups 
(forced sniff). If the female displayed complete maternal behavior (CMB; retrieval of all 
pups to a single nest area, licking/grooming pups, and adoption of nursing posture), an 
additional 15 min nursing observation was made. The first day and first hour during 
which these behaviors were observed was used to compute the latency to onset of 
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maternal behavior. Animals that did not show maternal behavior during the testing period 
were assigned latencies of one day beyond testing. 
 On the first day of testing, subjects were presented with pups one at a time. At the 
start of the observation period (time=0 min), one pup iss placed in the quadrant farthest 
away from the female’s nesting quadrant; after 15 min have elapsed, a second pup is 
placed in a separate quadrant that is also not the nesting quadrant; at the 30-min spot-
check, the last pup is placed. If a female attacked pups on the first day, her pups were 
immediately removed and testing was terminated for that day. The following morning, 
the female was once again presented with pups one at a time. Females who did not attack 
pups were subsequently given all three freshly nourished pups at the same time at the 
start of testing for the remainder of the test days.  
 Approximately 5 hr following pup presentation, all females were spot-checked 
and the location of the female and the three pups was recorded. If a female was 
completely maternal, a 15 min nursing observation was taken.   
 The following morning, the location of the female and pups was noted, the pups 
were removed and replaced with three freshly nourished pups taken from donor females. 
This procedure was repeated until the female showed complete maternal behavior during 
the 1-hr testing period in the morning for 2 consecutive mornings or until 5 days had 
elapsed. If a female displayed complete maternal behavior on the two consecutive days of 
drug injection, an additional test was performed to determine whether the female could 
respond maternally to pups in the absence of drugs.   
 
Histology 
 Subjects were perfused with saline followed by formalin while under deep 
anesthesia. Brain slices 40µm thick were cut using a freezing microtome and stained with 
cresyl violet. Microscopic examination mapped the location of the cannula injection sites. 
Females whose brains contained excessive damage or misplaced cannulae were removed 
from the study. 
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Statistics 
 Non-parametric statistical analysis and t tests were used to measure whether 
differences existed between groups in the latency to onset of maternal behavior. For all 
analyses, a significance level of p < .05 was used. Because both Experiment 1 and 2 each 
contained only two groups, the Mann-Whitney U test was used to analyze median 
latencies to onset of complete maternal behavior and mean latencies to approach and sniff 
pups. The t test was used to analyze mean latencies to sniff and approach pups. 
Frequency data in Experiments 1 and 2 were analyzed with the Fischer exact probability 
test.  
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III. Experiment 1A and 1B 
A. Introduction 
 Recall that both DA and estradiol have been show to act directly on the MPOA to 
stimulate the onset of maternal behavior in rats. Classical investigations of estrogenic 
effects on the MPOA have maintained that estrogen, administered at the time of surgery, 
has a long-lasting or genomic effect. Numan et al. (1977) applied crystalline estradiol 
benzoate (EB) through cannula implants to the MPOA immediately following HO 
surgery. The females were tested 48 hr after the administration of EB and displayed 
significantly shorter sensitization latencies to initiate maternal behavior compared to 
control animals, suggesting that estradiol may exerts its effects over a long period of 
time. 
 In examining the effects of increased DA activity at the level of the MPOA, our 
research found that 15HO females, when tested 20 minutes post-injection with a DA D1 
agonist, displayed immediate maternal behavior (Stolzenberg et al., 2007). These results 
seem to indicate that DA is having a rapid neuromodulatory effect on neurons of the 
MPOA. However, in regards to investigating the effects of estradiol, the classical 
paradigm consists of waiting 48 hr after concurrent HO and estradiol administration 
before presenting females with pups. Partially, this delay in commencing behavioral 
testing was due to the time it takes EB to enter the bloodstream when administered 
subcutaneously. When injecting EB into the bloodstream, there are multiple ambiguities 
that are left unresolved: how long does it take before the estradiol reaches its peak and 
exhibits maximum effects on the MPOA? Within the 48 hr waiting period, is estradiol 
activating the synthesis of new proteins within the neuron or is it carrying out rapid 
effects at the membrane level? An important consideration is that Numan et al. (2007) 
examined vaginal smears of 16HO + E females and found that estradiol levels did no 
reach their peak until approximately 48 hr after EB crystals were given, suggesting that 
estradiol might be having a genomic effect. 
 It is believed that the regulation of neuronal activity by estrogen hormones 
proceeds by both genomic- and nongenomic-mediated mechanisms (Bjornstrom & 
Sjoberg, 2005; Thompson & Moss, 1994). According to the classical model, estradiol 
diffuses through the membrane, forms a complex with its receptor, and affects 
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transcription of selected genes. However, additional evidence has supported the 
nongenomic actions of estradiol, which are too rapid (seconds to minutes) to be 
accounted for by activation of RNA and protein synthesis. There is a subpopulation of 
estrogen receptors embedded in the plasma membrane, which are coupled to G-proteins 
and exert their affects through the initiation of intracellular signaling cascades. Abraham, 
Han, Todman, Korach, and Herbison (2003) have shown that estradiol can indeed have 
rapid effects in their investigation of estradiol action on gonadotropin-releasing hormone 
(GnRH) neurons of ovariectomized mice in vivo. In regards to the phosphorylation status 
of cAMP response element-binding protein (CREB), results indicated that the percentage 
of GnRH neurons expressing phosphorylated CREB increased more than six-fold 15 
minutes after estradiol administration.  
 Now that we possess the ability to inject subcutaneous estradiol on the day of 
testing (due to the availability water-soluble estradiol), we can investigate whether 
estradiol can produce its effects rapidly. This method will allow us to investigate whether 
DA and estradiol affect the MPOA through similar pathways and will inform future 
research in exploring which mechanism, if any, DA and estradiol share.   
 
B. Method: Experiment 1A 
Injections 
48 hr after HO, all females were subcutaneously injected with either: 20µg/kg of 
estradiol dissolved in a carrier vehicle of saline and cyclodextrin (WE20) or 20µg/kg of 
cyclodextrin dissolved in saline (W20) depending on their test condition. Each group 
received dosages which were measured according to their weight and were injected 
subcutaneously at the nape of the neck. Injections were made one hour before behavioral 
testing took place.  
  
Groups 
1. WE20 (n = 12): Females underwent HO surgery on Day 15 of pregnancy. 48 hr after 
HO, females were injected with estradiol in cyclodextrin and saline (sc). 1 hr following 
injection, females were presented with three stimulus pups. Females were presented with 
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pups every subsequent day of testing (Days 0-5) until they displayed complete maternal 
behavior on two consecutive mornings. 
2. W20 (n = 10): Females underwent HO surgery on Day 15 of pregnancy. 48 hr after 
HO, females were injected with cyclodextrin in saline (sc). 1 hr following injection, 
females were presented with three stimulus pups. Females were presented with pups 
every subsequent day of testing (Days 0-5) until they displayed complete maternal 
behavior on two consecutive mornings. 
 
Behavioral Testing 
 Females were tested each morning according to the procedure described in the 
general methods section. The same criteria of maternal responsiveness (retrieving, 
grouping, and nursing) were used to deem the female fully maternal. Behavioral testing 
proceeded for 6 testing days, which were designated Days 0-5. If a female did not display 
complete maternal behavior within the 6 testing days, she was assigned a latency of 5 
days. 
 
Method: Experiment 1B 
Injections 
 Forty-eight hours after HO, all females were subcutaneously injected with either:  
100µg/kg of 17 β-estradiol dissolved in a carrier vehicle of saline and cyclodextrin 
(WE100) or 100µg/kg of cyclodextrin dissolved in saline (W100) depending on their test 
condition. Each group received dosages which were measured according to their weight 
and were injected subcutaneously at the nape of the neck. Injections were made one hour 
before behavioral testing took place.  
 
Groups 
1. WE100 (n = 9): Females underwent HO surgery on Day 15 of pregnancy. 48 hr after 
HO, females were injected with estradiol in saline and cyclodextrin (sc). 1 hr following 
injection, females were presented with three stimulus pups. Females were presented with 
pups every subsequent day of testing (Days 0-5) until they displayed complete maternal 
behavior on two consecutive mornings. 
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2. W100 (n = 9): Females underwent HO surgery on Day 15 of pregnancy. 48 hr after 
HO, females were injected with cyclodextrin in saline (sc). 1 hr following injection, 
females were presented with three stimulus pups. Females were presented with pups 
every subsequent day of testing (Days 0-5) until they displayed complete maternal 
behavior on two consecutive mornings. 
 
Behavioral Testing 
 Females were tested each morning according to the procedure described in the 
general methods section. The same criteria of maternal responsiveness (retrieving, 
grouping, and nursing) were used to deem the female fully maternal. Behavioral testing 
proceeded for 6 testing days, which were designated Days 0-5. If a female did not display 
complete maternal behavior within the 6 testing days, she was assigned a latency of 6 
days.  
 
D. Results: Experiment 1A 
 Experiment 1A examined the rapid effects of subcutaneous estradiol injection on 
sensitization latencies to show complete maternal behavior in 15HO rats. The median 
latencies to the onset of maternal behavior are shown in Table 2. Mann-Whitney U tests 
did not reveal an overall significant difference between the two groups at the end of 
observation during the day, U = 41.5, p = .10. However, the median latency to show 
maternal behavior during the first hour of testing for females receiving 20-µg of estradiol 
(n = 12) was 1 day, significantly shorter than that shown by females receiving 0-µg of 
estradiol (n = 10), Mann-Whitney U test: U = 33.5, p = .035. As shown in Table 2, the 
mean latency to approach and sniff pups (averaged over Days 0-1) did not differ between 
any of the groups, T test: t = 0.61, p = .59.  
 The cumulative percentages of females in each group showing full maternal 
behavior during the first hour of testing on each day are shown in Figure 4. The Fisher 
exact probability test indicated that a significantly higher proportion of females in the 
WE20 group were showing maternal behavior by the end of the hour on Day 1 of testing 
when compared to the W20 group. At the end of the hour on Day 1, 75% of 15HO 
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females subcutaneously injected with estradiol showed full maternal behavior, compared 
with only 30% of vehicle-injected females. 
  
E. Results: Experiment 1B 
 Experiment 1B examined the rapid effects of subcutaneous estradiol injection on 
sensitization latencies to show complete maternal behavior in 15HO females (Table 2). 
The median latency for females receiving 100-µg of estradiol (n = 9) to show complete 
maternal behavior by the end of the test day was 1 day, significantly shorter than the 3-
day latency of the vehicle-treated group (n = 9; Mann-Whitney U test, U = 23, p = .05). 
When the median latency to show maternal behavior during the first hour of maternal 
behavior testing (rather than by the end of the test day) was analyzed, the 100-µg group 
still showed maternal behavior significantly sooner (Mdn = 1 day) than the 0-µg group 
(Mdn = 4 days; Mann-Whitney U test, U = 20, p = .028). There was no significant 
difference between groups in mean latency to sniff and approach pups, T-test: t =  -1.75, 
p = 0.12. 
 The cumulative percentages of females in each group showing full maternal 
behavior during the day one each test day are shown in Figure 5. By Day 1 of testing, 
89% of 15HO females subcutaneously injected with 100-µg of estradiol showed full 
maternal behavior, compared with only 33% of vehicle-injected females. The Fisher 
exact probability test indicated that this difference was significant (p < .05).  
 
F. Discussion: Experiments 1A and 1B 
 Previous experiments indicate that both subcutaneous estradiol administration 
(Rosenblatt et al., 1998) and increased DA activity on D1 receptors in the NA or MPOA 
(Stolzenberg et al., 2007) can stimulate immediate onset of maternal behavior in 15HO 
females. Given that the D1 agonist was microinjected 20 min before behavioral testing 
began, and that systemic estradiol injection seemed to yield similar results to DA action 
on NA or MPOA, we hypothesized that estradiol could be having a rapid effect on neural 
circuits integral to maternal behavior. However, this could not be proven because the 
classical paradigm has been to administer estradiol on the day of HO surgery, 48 hr 
before behavioral testing begins (Numan et al., 1977; Rosenblatt et al., 1998).  
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 Experiments 1A and 1B examined the ability of estradiol to act on neurons of the 
MPOA and mesolimbic DA system through rapid membrane-mediated mechanisms. Our 
findings indicate that estradiol injection (sc) 1 hr before testing is having a rapid effect in 
the facilitation of maternal behavior in 15HO females. In addition, our results indicate 
that this effect seems to be dose-dependent, as females receiving a higher dosage (100 
µg) of estradiol displayed a larger difference in latency to onset of complete maternal 
behavior compared to the respective control group than females injected with 20 µg (see 
Table 2). These results suggest that increased estradiol stimulation of neural circuits 
results in rapid molecular changes, which enable the partially primed female to 
immediately initiate maternal behavior.  
  If estradiol is indeed exerting is effects rapidly, one site it is likely affecting is the 
MPOA. The Numan group (1977) has shown that direct administration of crystalline 
estradiol to the MPOA of 15HO females results in immediate onset of maternal behavior 
when females were presented with pups 48 hr after surgery. Because females were 
already in estrous on the first day of testing, it is unclear what exact role estrogen plays in 
priming neural circuits: the females could have been affected by the already high 
estrogen levels in the brain, estradiol could have exerted a novel effect, or estradiol might 
have supplemented endogenous estrogen activity in facilitating the rapid initiation of 
maternal responsiveness. Experiments 1A and 1B take the first step in examining how 
estradiol exerts its effects by looking at which molecular mechanisms are involved in ER 
signaling. 
 Given the anatomical proximity of the MPOA and NA, it is possible that estradiol 
could have also exerted its effects at the NA. This suggestion is particularly relevant to 
the exploration of DA activity at D1 receptors in the NA. Based on the view that estradiol 
action at the MPOA stimulates maternal behavior by activating the mesolimbic DA 
system, we hypothesized that upregulation of DA in the NA substitutes for a lower level 
of estradiol priming of MPOA efferents in 15HO females. Recent evidence has shown 
that estradiol also acts at the NA (Walf, Rhodes, Meade, Harney, & Frye, 2007) and 
results from Experiments 1A and 1B indicate that it could be exerting its effects through 
nongenomic and/or rapid-acting pathways. Taken together, these findings provide a 
mechanism by which estradiol and DA can act on the NA in the same way.  
 23 
 One important consideration is that the NA does not contain intracellular estrogen 
receptors (Shughrue, Lane, & Merchenthaler, 1997) suggesting that estradiol acts at the 
membrane of neurons in the NA. Membrane-mediated estradiol effects, which are 
typically nongenomic, have to potential to activate either PLC (Qui, Bosch, Tobias, 
Grandy, Scanlan, Ronnekleiv & Kelly, 2003) or PKA (Lagrange, Ronnekleiv, & Kelly, 
1997) signaling cascades. Given that our findings indicate that estradiol is most likely 
having rapid effects at the membrane (and not in the nucleus), it is possible that DA and 
estradiol could be affecting similar second messenger systems in NA neurons. 
Experiment 2 sheds light on this issue by posing the question: if DA is substituting for 
estradiol action at the NA, which mechanisms are involved and are they operating 
through similar mechanisms?  
 The classical mechanism of estrogen receptor (ER) action involves estrogen binding 
to receptors in the nucleus. However, Bjornstrom and Sjoberg (2005) have shown that 
estradiol action on transmembrane receptors can not only lead to altered function of 
proteins but also to regulation of gene expression. This suggests a convergence of 
genomic and nongenomic actions of ERs at the membrane level. Therefore, it is possible 
that estradiol action at the membrane of NA neurons may still be exerting long-term 
effects on gene transcription. Rapid-acting effects do not always refer to nongenomic 
actions. Signaling transduction pathways are one way by which nongenomic actions of 
estradiol are connected to genomic responses. Future research in our laboratory might 
explore which protein kinase-mediated pathways are activated by estradiol action at the 
membrane.  
 Additionally, a further examination of genomic- and nongenomic-mediated effects 
of estradiol might include direct injection of estradiol into the MPOA and behavioral 
testing shortly afterward. Literature previously reviewed indicates that the MPOA is a 
key site where estradiol acts to increase efferent output to the mesolimbic DA system and 
results from future studies might suggest whether estradiol utilizes similar mechanisms in 
the MPOA and NA. To measure the extent of rapid estradiol action, estrogen levels may 
be tested 48 hr after injection to see whether estradiol had degraded.   
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Table 2. 
Outcome Measures (with Standard Errors) in 15HO Female Rats That Received 0-, 20-, 
or 100-µg Doses of SKF 83959 Subcutaneously 
 
Water E 
Groups 
 
 
N 
 
Mean ± SE latency to 
approach- sniff pups (s) 
 
Median onset to full maternal 
behavior (days) 
   day hour 
WE20 12 
          32.21± 12.0166 
 
0.5 (0-2) 1 (0-2)* 
W20 10 60.15 ± 44.2175 2 (0-6) 2 (1-6) 
WE100 9 26.61 ± 6.35 1 (0-1)* 1 (1-1.5)* 
W100 9 137.83 ± 2.19 3 (0-4) 4 (1-4.5) 
 
Note. For each female, latency to sniff and approach pups was averaged over Days 0-1 of 
testing. Interquartile ranges are shown in parentheses. WE refers to 17 β-estradiol 
dissolved in cyclodextrin and saline. * Significantly different from corresponding vehicle 
group, Mann-Whitney U test, p < .05.  
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Figure 3.    Experimental timeline for Experiment 1A & 1B. The day of mating was 
considered Day 0 of pregnancy. All females were hysterectomized-ovariectomized on 
Day 15 of pregnancy. Females in both groups were subcutaneously injected and exposed 
to pups on Day 0, what would have been Day 17 of pregnancy. Injections continued for 
two consecutive days (Day 0-1). The testing period lasted for six consecutive days (Day 
0-5). 
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Figure 4.   Cumulative percentage of 15HO female rats showing full maternal behavior 
during the 1 hr observation period on each test day. Females received subcutaneous 
injections of either 0 (W20) or 20 (WE20) µg of 17 β-estradiol dissolved in cyclodextrin 
and saline on Days 0 and 1 of testing. *Significantly different from vehicle-injected 
group, Fisher exact probability test, p < .05. 
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Figure 5.    Cumulative percentage of 15HO female rats showing full maternal behavior 
on each test day. Females received subcutaneous injections of either 0 (W100) or 100 
(WE100) µg of 17 β-estradiol dissolved in cyclodextrin and saline on Days 0 and 1 of 
testing. * Significantly different from vehicle-injected group, Fisher exact probability 
test, p < .05 
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IV. Experiment 2 
A. Introduction 
The hormonal changes which occur during pregnancy and pregnancy termination 
are essential for the immediate display of maternal behavior at parturition. In the fully 
maternal female rat, we have hypothesized that circulating hormones, especially 
estradiol, prime central sites to respond to pup stimuli with the immediate onset of 
maternal behavior. We also hypothesized that DA inhibits excitatory transmission in the 
NA and the NA then releases the VP from inhibition, allowing the VP to respond to pup 
inputs and ultimately leading to immediate initiation of maternal responsiveness (see 
Figure 2). Specifically, we suggested that estradiol action on the MPOA stimulates the 
release of DA in the NA in response to pup stimuli and increased DA mediates proactive 
maternal responses toward pups. The partially primed female (15HO) experiences a 
suboptimal amount of estradiol action on the MPOA. As a consequence, less DA is 
released into the NA, which necessitates more pup exposure before the female initiates 
maternal behavior. However, we also indicated that DA action on the MPOA stimulates 
immediate maternal behavior in 15HO females (Stolzenberg et al., 2007), probably 
through the increased output of MPOA efferents and ultimately, of DA into the NA. Note 
that while we have argued that DA action at the level of the MPOA facilitates the output 
of MPOA efferents, we have also proposed that DA action on the level of the NA 
depresses output. As a first step to understanding how DA mediates these different effects 
on neural circuitry, we are exploring the intracellular mechanisms by which DA mediates 
its effects in the NA. 
In order to examine potential DA-D1 receptor mechanisms, it is necessary to 
review some basic information on D1 receptors. Unlike excitatory and inhibitory 
neurotransmitters, DA action on its receptors is neuromodulatory; instead of causing 
direct inhibition or excitation, DA receptors are coupled to G-proteins. The classical view 
stipulates that D1 receptors initiate an intracellular signaling cascade in which the 
enzyme adenylate cyclase (AC) catalyzes the conversion of ATP to cyclic AMP (cAMP) 
and results in the activation of protein kinase A (PKA) (Missale, Nash, Robinson, Jaber 
& Caron, 1998) (See Figure 8). In addition to the classical cAMP-coupled mechanism, 
relatively new evidence suggests that there is another sub-class of DA D1 receptors that 
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affects an entirely new signaling cascade: the phospholipase C (PLC) 
phosphatidylinositol cascade, which is linked to protein kinase C (PKC) (O’Sullivan, 
Roth, Kinsella, & Waddington, 2004; Undie & Friedman, 1994). In lieu of AC, PLC 
catalyzes the hydrolysis of phosphatidylinositol (PIP2) into diaglycerol (DAG) and 
inositol triphosphate (IP3) (See Figure 9).  
Evidence suggests that DA D1-PLC linked receptors might mediate attenuation of 
excitatory input to the NA. Harvey and Lacey (1996, 1997) have shown that DA action 
on D1 PLC receptors in the NA promotes inhibition of glutamatergic stimulation in vitro. 
This effect was not blocked by cAMP or PKA inhibition, suggesting that DA action at the 
level of the NA could be mediated by a separate signaling mechanism, the PLC cascade. 
In support of this hypothesis, Chergui and Lacey (1999) have shown that pretreatment of 
NA brain slices with a PKC inhibitor blocked DAergic depression of excitatory 
postsynaptic potentials (EPSP). Similarly, in the neonatal hippocampus, DA-induced 
inhibition of EPSPs is mediated by D1-PLC linked receptors (Noriyama, Ogawa, 
Yoshino, Yamashita, & Kishimoto, 2006). Based on these findings, which indicate that 
activation of DA D1 PLC receptors has an inhibitory effect on the NA, we hypothesize 
that DA might be inhibiting GABAergic output to the VP, thereby releasing the VP from 
inhibition so that it can respond to pup stimuli.  
Experiment 2 explores the possibility that the DA D1 agonist SKF 83959, which 
is specific for DA D1 PLC signaling, will stimulate maternal behavior when injected into 
the NA. It is important to note that while SKF 83959 selectively stimulates DA D1 PLC 
receptors, it also blocks the effect of DA D1 cAMP receptors (Jin, Goswami, Cai, Zhen, 
& Friedman, 2003).  
 
B. Method 
Intracranial Injections 
To acclimate subjects to the intracranial injection procedures, females were taken 
to the injection room 24 hr after HO. There, the experimenter held the rat and removed 
and replaced the inner style that kept the guide cannula occluded. 
 48 hr after HO, females were injected with either: 0 µg (NAD1C) or 0.5µg 
(NAD1PLC) of SKF 83959 depending on their test condition. Each dose of SKF 83959 
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was dissolved in 0.5µl of sterile H2O and injected bilaterally on Days 0, 1, and 2 of 
behavioral testing. 
 
Groups 
1. NAD1PLC (n = 8): Females underwent cannula implantation surgery on day 1 of 
pregnancy, were hysterectomized-ovariectomized on day 15 of pregnancy, and then 
intracranially injected with SKF 83959 48 hr post-HO. 20 min after injection, females 
were presented with three stimulus pups. Females were presented with pups every 
subsequent day of testing (Days 0-5) until they displayed complete maternal behavior on 
two consecutive mornings. 
2. NAD1C (n = 7): Females underwent cannula implantation surgery on day 1 of 
pregnancy, were hysterectomized-ovariectomized on day 15 of pregnancy, and then 
intracranially injected with distilled water 48 hr post-HO. 20 min after injection, females 
were presented with three stimulus pups. Females were presented with pups every 
subsequent day of testing (Days 0-5) until they displayed complete maternal behavior on 
two consecutive mornings. 
 
Behavioral Testing 
Females were tested each morning according to the procedure described in the 
general methods section. The same criteria of maternal responsiveness (retrieving, 
grouping, and nursing) were used to deem the female fully maternal. Behavioral testing 
proceeded for 7 testing days, which were designated Days 0-6. If a female did not display 
complete maternal behavior within the 6 testing days, she was assigned a latency of 6 
days. 
 
C. Results 
 Experiment 2 examined the effects of microinjection of SKF 83959 (a D1 DA 
PLC receptor agonist) into the NA on sensitization latencies to show complete maternal 
behavior in 15HO rats (see Table 3). Statistical analyses did not reveal an overall 
significant difference in median latency between the two groups at either the end of the 
test day or the end of the first hour of observation, Mann-Whitney U test: U = 24.5, p = 
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.6025; U = 25, p = .64, respectively. However, when the mean latency to approach and 
sniff pups (averaged over Days 0-2 of testing) was analyzed, the females receiving 0-µg 
of SKF 83959 (n = 7) approached and sniffed pups significantly sooner than the 0.5-µg 
group (n = 8). As shown in Table 3, the NAD1C group, which received 0-µg of drug, 
showed a mean latency to approach and sniff pups of 32.86 seconds, which was 
significantly shorter than that shown by the NAD1C group, t-test: t = -2.89,  p = 0.02.  
 The cumulative percentages of females in each group showing full maternal 
behavior during the day on each test day are shown in Figure 7. There were no significant 
differences between the two groups during the six-day testing period.   
 
D. Discussion 
 Previous research has shown that (1) increased DA activity at D1 receptors in the 
NA promotes maternal behavior in 15HO female rats (Stolzenberg et al., 2007) and (2) 
depression of DA action on the NA disrupts maternal behavior in postpartum female rats 
(Numan et al., 2005a). As an important complement to these findings, the present study 
provides insight into the distinct intracellular signaling cascades utilized by DA at the 
level of the NA to facilitate immediate maternal responsiveness in 15HO females. 
 We hypothesized that DA action on D1 receptors is attenuating the impact of 
excitatory inputs on the NA and releasing the VP from inhibition. Based on the literature 
reviewed, we had reason to believe that DA D1 PLC receptors could be mediating this 
effect. The results from the current study indicate that selective stimulation of DA D1 
PLC receptors is not having a facilitatory effect on maternal behavior.  
The work of Stolzenberg et al. (2007) showed that DA action on D D1 receptors 
facilitates immediate onset of maternal behavior. SKF 38393 was used as the 
complement of SCH 23390, a DA D1 receptor antagonist, which was found to disrupt 
retrieval behavior in postpartum animals when injected into the NA (Numan et al., 
2005a). Previous findings have shown that SKF 38393 is capable of stimulating both 
PLC- and AC-coupled signaling cascades while SCH 23390 is capable of blocking both 
pathways (Jin et al., 2003). While it is clear that DA acts on D1 receptors to promote 
maternal behavior, it is not clear which signaling cascade is initiated.  
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The above findings contributed to the formation of our current neural model, 
which suggests that DA binding D1 receptors in the MPOA leads to increased output 
while DA D1 stimulation of the NA results in decreased output to the VP. A key question 
arises from this model: are there distinct intracellular mechanisms that mediate DA D1 
effects in the MPOA and NA? While both areas have been shown to mediate 
dopaminergic inputs in the regulation of maternal behavior, lesion studies have shown 
that an intact MPOA is essential for maternal behavior while an intact NA is not (see 
Numan & Insel, 2003). An implication of these studies is that DA action on D1 receptors 
exerts its effects through different mechanisms in different areas of the brain.  
An understanding of the signaling cascade might also provide insight about the 
actions of estradiol on the MPOA and NA. We have concluded that DA action on D1 
receptors might be substituting for estradiol stimulation of the mesolimbic DA system. 
Estradiol administered on Day 15 of pregnancy systemically has been shown to increase 
efferent output of the MPOA, but due to the nonspecific nature of systemic injection, 
estrogen might also be acting on the NA. Findings from Experiment 1 indicate that 
subcutaneous injection of estradiol is having a rapid effect in facilitating maternal 
responsiveness. If estradiol is having a membrane-mediated effect, then which pathways 
are involved? There is evidence that estradiol can act in the NA (Walf et al., 2007) and 
that it can bind to novel receptors that are coupled to PLC (Qui et al., 2003) and PKA 
signaling pathways (Lagrange et al., 1997). Results from the current study might help us 
gain a better understanding of the ways in which estradiol exerts its effects and whether 
estradiol and DA are utilizing similar mechanisms.  
Although we hypothesized that D1 PLC receptors might mediate DA action on the 
NA due to evidence that PLC signaling at D1 receptors dampens excitatory input to the 
NA, it appears that these receptors are not involved in the facilitatory effects of SKF 
38393 in the NA on maternal behavior. In fact, the data from Experiment 1 shows that 
15HO females treated with 0.5µg of SKF 83959 (NAD1PLC) had a median sensitization 
latency of 6 days, which was 1 day longer than the median latency of 15HO females who 
did not receive any drug (NAD1C). Further, and perhaps more striking, is the fact that the 
6-day average latency of the NAD1PLC group is significantly longer than that of 15HO 
females, who typically display 2-3 day latencies (See Table 1). 
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 One possible interpretation of these findings is that administration of SKF 83959 
actually depressed neural circuits that are essential for the facilitation of maternal 
behavior. SKF 83959 is selectively linked to DA D1 PLC signaling due to its ability to 
induce IP3 formation when bound to DA D1 receptors. However, while SKF 83959 
activates PLC, it also inhibits the action of AC by preventing endogenous DA from 
binding to DA D1 PKA receptors (Jin et al., 2003; Ming, Zhang, Long, Wang, Chen, & 
Zhen, 2006; Undie et al., 1994). Therefore, the possibility must be considered that the 
inhibition of AC pathways blocked the effects of DA on the NA and consequently 
depressed maternal behavior.  
Another possibility is that both signaling cascades need to be activated to 
facilitate maternal behavior. It has been shown that stimulation of the PLC signaling 
cascade causes a depression of glutamatergic excitation at the NA (Chergui & Lacey, 
1999). It is possible that both PKA and PLC signaling cascades are participating, to a 
certain extent, in conjunction with one another to facilitate the onset of maternal behavior 
in the NA. Future experiments can explore whether facilitatory actions of DA on D1 
receptors are mediated by PKA signaling alone or by both PKA and PLC. Very recent 
evidence has suggested that a possible convergence of the two signaling cascades might 
be the key to aspects of maternal behavior. Frye and Walf (2008) have shown that the 
rapid action of progestin proceeds through activation of PKA or PLC in the VTA at DA 
D1-like receptors to facilitate lordosis. These findings suggest that DA action on the NA 
is complex and might involve more than one signaling pathway. In addition, it might also 
be true that DA acts on two different populations of neurons in the NA and that each sub-
population activates a separate signaling mechanism.  
To further examine this issue, future research in our laboratory intends to explore 
the direct effects of estradiol on the NA. Given that our findings indicate that PLC alone 
does not mediate DA action on D1 receptors and that estrogen receptors can be activated 
by a DA D1-cAMP-PKA mechanism (Gangolli, Connelly, &  O’Malley, 1997; Lagrange 
et al., 1997), it would be informative to explore the importance of the AC coupled 
pathway. 
Based on findings from the current study, it seems that activation of PKA might 
be integral in onset of maternal behavior. Looking at our data, blockade of D1 AC 
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receptors seems to have an inhibitory effect on maternal responsiveness. Even sniff 
latencies, which had not been affected in previous studies involving upregulation of DA 
on D1 receptors, were significantly longer in females treated with SKF 83959 (see Table 
2). These data suggests that treatment with SKF 83959 might specifically dampen the 
female’s ability to initiate proactive voluntary maternal responses, especially oral 
maternal behaviors such as sniffing/licking and retrieving. Various studies have shown 
that DA D1 receptor antagonism in both the MPOA (Miller & Lonstein, 2005) and NA 
(Numan et al., 2005) result in longer latency to approach pups and primarily disrupted 
retrieval behavior. Importanly, DA D1 receptor antagonists inhibit the actions of AC. 
Given that our results show significantly longer sniff latencies in females treated with 
SKF 83959 than in control animals, it seems that blockade of the PKA signaling pathway 
generally depresses the female’s ability to approach pups. Tactile input from the snout 
region triggers retrieval (Stern & Kolunie, 1989), indicating that perioral contact and 
olfactory input are essential for a female to initiate retrieval behavior. Perhaps inhibition 
of DA D1-AC coupled receptors in the NA lengthens the female’s time to approach pups 
and consequently, attenuates the ability of sensory stimulation to activate neural 
circuitries that are essential to maternal responsiveness.   
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Table 3. 
Outcome Measures (with Standard Errors) in 15HO Rats that received 0- or 0.5-µg 
Doses of SKF 83959 into the Nucleus Accumbens (NA) 
 
SKF 83959 
Groups 
 
 
N 
 
Mean ± SE latency to 
approach- sniff pups (s) 
 
Median onset to full maternal 
behavior (days) 
   day hour 
NA D1 PLC 8 
       157.4163 ±  40.84* 
 
6 (2-6) 6 (2-6) 
NA D1 C 7 32.86 ± 13.99 5 (2-6) 5 (2-6) 
 
Note. For each female, latency to sniff and approach pups was averaged over Days 0-2 of 
testing. Interquartile ranges are shown in parentheses. D1 PLC refers to SKF 83959, a 
D1-PLC coupled dopamine receptor agonist. * Significantly different from corresponding 
vehicle group (NA D1 C), Mann-Whitney U test, p < .05. 
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Figure 6.    Experimental timeline for Experiment 2. The day of mating was considered 
Day 0 of pregnancy. All females were implanted with cannulas on Day 1 of pregnancy 
and hysterectomized-ovariectomized on Day 15. Females in both groups were injected 
and exposed to pups on Day 0, what would have been Day 17 of pregnancy. Injection 
continued for three consecutive days (Day 0-2). The testing period lasted for seven 
consecutive days (Day 0-6).  
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Figure 7.    Cumulative percentage of 15HO female rats showing full maternal behavior 
on each test day. Females received bilateral microinjections of either 0- (NAD1C) or 0.5- 
(NAD1PLC) µg SKF 83959 (n = 7 and 8, respectively) into the NA on Days 0, 1, and 2 
of testing. Groups did not differ significantly.  
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Figure 8. Adenylyl cyclase coupled signaling cascade. The binding of DA to the 
receptor activates a G-protein, which in turn activates adenylyl cyclase. Adenylyl cyclase 
generates cAMP, which activates the downstream enzyme protein kinase A.  
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Figure 9.    Phospholipase C coupled signaling cascade. Activated G-proteins stimulate 
the enzyme phospholipase C (PLC). PLC splits PIP2 into DAG and IP3. DAG stimulates 
the downstream enzyme protein kinase C (PKC). IP3 stimulates the release of CA2+ from 
intracellular stores. The CA2+ can go on to stimulate various downstream enzymes.  
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Figure 10.    Microscopic analysis of cresyl violet stained section showing the location of 
SKF 83959 injection sites into the nucleus accumbens. Arrows point to injection sites in 
either hemisphere. All implants were located within the shell of the NA. CP, caudate 
putamen; OT, ocular tract.  
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 V. General Discussion 
 The three experiments performed were foundational in the investigation of the 
ways in which DA and the hormone estradiol facilitate maternal behavior in the NA and 
MPOA. Ultimately, the major goal of our laboratory is to determine the exact nature of 
the changes that occur in the brain at the immediate onset of maternal behavior and then, 
to determine which intracellular mechanisms participate in the promotion of maternal 
responsiveness. Experiments 1A and 1B paved new territory in the exploration of the 
nongenomic effects of estradiol. The results from both experiments suggest that estradiol 
is having a rapid effect, prompting further research to investigate which mechanisms are 
involved in estradiol action on the MPOA in the facilitation of maternal behavior. 
Experiment 2 suggests that the role of DA D1-activated signaling cascades in the NA 
merits further exploration. Contrary to the classical model, which stipulates that DA D1 
receptors regulate maternal behavior through an AC-coupled signaling mechanism, 
results from Experiment 2 indicate that DA action on D1 receptors in the NA might 
involve multiple G-protein coupled signaling cascades. 
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